The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goddard Glenn since 2014.
This trader's CIK number is 1581992.
At the time of last reporting, Goddard Glenn was the EVP, Chief Financial Officer of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA).
Also see all insider trading activities at Intellia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | AGIO | 0 | $0 | 56,000 | $6,087,476 | 60,856 | $909,977 |
| 2014 | AGIO | 0 | $0 | 86,500 | $3,769,224 | 86,500 | $142,565 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | NTLA | 0 | $0 | 5,365 | $158,052 | 0 | $0 |
| 2023 | NTLA | 0 | $0 | 0 | $0 | 6,124 | $0 |
| 2022 | NTLA | 0 | $0 | 1,013 | $113,699 | 3,062 | $0 |
| 2021 | NTLA | 0 | $0 | 53,482 | $8,444,338 | 53,482 | $956,111 |
1. Agios Pharmaceuticals, Inc. (AGIO)
2. Intellia Therapeutics, Inc. (NTLA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-09-24 | AGIO | Sale | 6,000 | 85.97 | 515,820 |
| 2015-09-24 | AGIO | Option Ex | 10,856 | 11.55 | 125,386 |
| 2015-07-23 | AGIO | Sale | 7,000 | 120.45 | 843,150 |
| 2015-07-23 | AGIO | Option Ex | 7,000 | 27.37 | 191,590 |
| 2015-07-17 | AGIO | Option Ex | 13,000 | 8.79 | 114,322 |
| 2015-07-17 | AGIO | Sale | 13,000 | 113.71 | 1,478,230 |
| 2015-05-27 | AGIO | Option Ex | 2,171 | 23.10 | 50,150 |
| 2015-05-27 | AGIO | Sale | 2,171 | 120.05 | 260,628 |
| 2015-03-16 | AGIO | Sale | 10,000 | 106.24 | 1,062,400 |
| 2015-03-16 | AGIO | Option Ex | 10,000 | 18.48 | 184,770 |
| 2015-02-13 | AGIO | Option Ex | 1,316 | 23.10 | 30,399 |
| 2015-02-13 | AGIO | Sale | 1,316 | 120.31 | 158,327 |
| 2015-02-09 | AGIO | Option Ex | 15,000 | 11.89 | 178,410 |
| 2015-02-11 | AGIO | Option Ex | 1,513 | 23.10 | 34,950 |
| 2015-02-09 | AGIO | Sale | 15,000 | 105.81 | 1,587,150 |
| 2015-02-11 | AGIO | Sale | 1,513 | 120.14 | 181,771 |
| 2014-11-03 | AGIO | Option Ex | 2,000 | 4.87 | 9,738 |
| 2014-11-03 | AGIO | Sale | 2,000 | 81.71 | 163,420 |
| 2014-10-01 | AGIO | Sale | 1,500 | 60.07 | 90,105 |
| 2014-10-01 | AGIO | Option Ex | 1,500 | 9.05 | 13,575 |
| 2014-09-26 | AGIO | Sale | 17,500 | 56.53 | 989,275 |
| 2014-09-26 | AGIO | Option Ex | 17,500 | 4.03 | 70,455 |
| 2014-09-02 | AGIO | Option Ex | 10,000 | 1.51 | 15,140 |
| 2014-09-02 | AGIO | Sale | 10,000 | 46.30 | 463,000 |
| 2014-07-01 | AGIO | Option Ex | 3,500 | 1.17 | 4,077 |
| 2014-07-01 | AGIO | Sale | 3,500 | 46.52 | 162,820 |
| 2014-05-01 | AGIO | Option Ex | 2,000 | 1.17 | 2,330 |
| 2014-05-01 | AGIO | Sale | 2,000 | 42.39 | 84,780 |
| 2014-04-07 | AGIO | Sale | 2,000 | 45.17 | 90,340 |
| 2014-04-07 | AGIO | Option Ex | 2,000 | 1.51 | 3,028 |
| 2014-04-01 | AGIO | Option Ex | 4,000 | .58 | 2,312 |
| 2014-04-01 | AGIO | Sale | 4,000 | 38.08 | 152,320 |
| 2014-03-06 | AGIO | Option Ex | 5,468 | .47 | 2,559 |
| 2014-03-07 | AGIO | Option Ex | 12,000 | .58 | 6,935 |
| 2014-03-06 | AGIO | Sale | 5,468 | 35.54 | 194,332 |
| 2014-03-07 | AGIO | Sale | 12,000 | 45.10 | 541,200 |
| 2014-02-18 | AGIO | Sale | 3,532 | 35.06 | 123,831 |
| 2014-02-18 | AGIO | Option Ex | 3,532 | .47 | 1,652 |
| 2014-02-10 | AGIO | Option Ex | 6,000 | .47 | 2,808 |
| 2014-02-10 | AGIO | Sale | 6,000 | 30.44 | 182,640 |
| 2014-01-27 | AGIO | Sale | 7,000 | 26.29 | 184,051 |
| 2014-01-27 | AGIO | Option Ex | 7,000 | .47 | 3,276 |
| 2014-01-21 | AGIO | Option Ex | 10,000 | .47 | 4,680 |
| 2014-01-21 | AGIO | Sale | 10,000 | 34.71 | 347,110 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-03 | NTLA | Sale | 5,365 | 29.46 | 158,052 |
| 2023-01-01 | NTLA | Option Ex | 3,062 | .00 | 0 |
| 2023-01-01 | NTLA | Option Ex | 3,062 | .00 | 0 |
| 2022-01-01 | NTLA | Option Ex | 3,062 | .00 | 0 |
| 2022-01-01 | NTLA | Sale | 1,013 | 112.24 | 113,699 |
| 2021-09-07 | NTLA | Option Ex | 3,482 | 14.58 | 50,767 |
| 2021-09-07 | NTLA | Sale | 3,482 | 180.12 | 627,177 |
| 2021-08-31 | NTLA | Sale | 24,800 | 160.22 | 3,973,456 |
| 2021-08-30 | NTLA | Sale | 5,200 | 156.88 | 815,765 |
| 2021-08-31 | NTLA | Option Ex | 24,800 | 16.93 | 419,740 |
| 2021-08-30 | NTLA | Option Ex | 5,200 | 19.27 | 100,204 |
| 2021-08-05 | NTLA | Option Ex | 20,000 | 19.27 | 385,400 |
| 2021-08-05 | NTLA | Sale | 20,000 | 151.40 | 3,027,940 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goddard Glenn (EVP, Chief Financial Officer of Intellia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.